AusBiotech

Telix launches international NOBLE Registry of SPECT-Based prostate cancer imaging agent April 20, 2021

Telix has announced the launch of the international NOBLE Registry of its ‘rest of world’ prostate cancer imaging agent and the dosing of the first patient.

Australian medtech consultancy merges with international leader April 20, 2021

An Australian consultancy has merged with an international equivalent in a move it says could open the way for Australian life science companies to access broader global markets.

Exopharm completes $12 million capital raise April 20, 2021

Exopharm (ASX:EX1) says it has received 'firm commitments' from institutional and sophisticated investors for 16,666,667 shares to raise a total of $12 million in a placement.

Race Oncology appoints chief medical officer April 20, 2021

Race Oncology (ASX:RAC) has announced the appointment of Dr David Fuller as its chief medical officer.

AusBiotech appoints new director - Dr James Campbell April 20, 2021

AusBiotech has announced the appointment of Dr James Campbell as a director of the organisation, contributing strong commercialisation and capital-raising expertise to the board.

Pharmaxis sells Bronchitol rights in Russia and completes placement April 15, 2021

Australian company Pharmaxis has sold Russian distribution rights to cystic fibrosis therapy BRONCHITOL (mannitol) and completed a $4.4 million placement to institutional investors.

Ex-AusBiotech CEO joins board of emerging local biotech April 15, 2021

Adelaide-based Australian biotechnology company Sementis has appointed former AusBiotech CEO and Medicines Australia chair Dr Anna Lavelle as an independent director.

Amplia completes dosing in phase one study of AMP945 April 15, 2021

Amplia Therapeutics (ASX:ATX), a company developing new drugs for the treatment for cancer and fibrosis, has announced it has successfully completed the dosing of subjects in its phase one clinical trial of its focal adhesion kinase inhibitor AMP945.

Zelira announces record revenue in the march quarter April 15, 2021

Zelira Therapeutics (ASX:ZLD) says it generated record quarterly product sales and licensing revenues of $225,000 for the March 2021 quarter, up 249 per cent from the previous six months.

CSL’s Plasma Protein Purification Challenge opens April 15, 2021

CSL Behring and Cicada Innovations’ new Plasma Protein Purification Challenge seeks to tackle some of the biggest challenges in plasma protein production and to save and improve lives.

Alcidion Group acquires UK company and confirms capital raise April 15, 2021

Informatics company Alcidion Group (ASX:ALC) has announced its acquisition of UK company ExtraMed, provided an update on its growth and released details of a $17.9 million capital raise.

Australian-led discovery could speed up bone implant recovery April 13, 2021

An international research team led by Monash University has uncovered a new technique it says could speed up recovery from bone replacements by altering the shape and nucleus of individual stem cells.

Most Read

Australian medtech consultancy merges with international leader

AusBiotech appoints new director - Dr James Campbell

Exopharm completes $12 million capital raise

Race Oncology appoints chief medical officer

Telix launches international NOBLE Registry of SPECT-Based prostate cancer imaging agent

New Stories

Telix launches international NOBLE Registry of SPECT-Based prostate cancer imaging agent

Australian medtech consultancy merges with international leader

Exopharm completes $12 million capital raise

Race Oncology appoints chief medical officer

AusBiotech appoints new director - Dr James Campbell

Pharmaxis sells Bronchitol rights in Russia and completes placement

Ex-AusBiotech CEO joins board of emerging local biotech

Sign In

Most Read

Australian medtech consultancy merges with international leader

AusBiotech appoints new director - Dr James Campbell

Exopharm completes $12 million capital raise

Race Oncology appoints chief medical officer

Telix launches international NOBLE Registry of SPECT-Based prostate cancer imaging agent

Follow Us

New Stories

Telix launches international NOBLE Registry of SPECT-Based prostate cancer imaging agent

Australian medtech consultancy merges with international leader

Exopharm completes $12 million capital raise

Race Oncology appoints chief medical officer

AusBiotech appoints new director - Dr James Campbell

Pharmaxis sells Bronchitol rights in Russia and completes placement

Ex-AusBiotech CEO joins board of emerging local biotech